Terns Pharmaceuticals, Inc.
TERN
$2.91
-$0.11-3.64%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -23.91M | -21.80M | -21.95M | -22.74M | -22.37M |
| Total Depreciation and Amortization | 169.00K | 214.00K | 206.00K | 240.00K | 236.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.60M | 1.78M | 4.19M | 3.89M | 3.15M |
| Change in Net Operating Assets | -4.30M | 5.22M | 1.10M | 2.43M | -3.81M |
| Cash from Operations | -24.44M | -14.58M | -16.46M | -16.18M | -22.80M |
| Capital Expenditure | -- | 0.00 | 0.00 | -13.00K | -29.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.96M | -94.35M | 31.75M | 42.20M | 8.03M |
| Cash from Investing | 1.96M | -94.35M | 31.75M | 42.19M | 8.00M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 74.00K | 617.00K | 163.37M | 399.00K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -6.00K | -313.00K | -75.00K | -- | -- |
| Cash from Financing | 68.00K | 304.00K | 163.29M | 399.00K | -- |
| Foreign Exchange rate Adjustments | -3.00K | -69.00K | 53.00K | -14.00K | -26.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -22.42M | -108.70M | 178.64M | 26.40M | -14.83M |